Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
Isla S. Mackenzie, Christopher J. Hawkey, Ian Ford, Nicola Greenlaw et autres
gb (code pays fourni par la source)
166 citations
The Lancet